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Pharmaceutical formulationsAbstract A facile, rapid, sensitive and validated spectrophotometric methods for the determina-
tion of desloratidine (DES) in pure and in dosage forms is described. The methods are based on
the formation of charge transfer complexes between DES and the chromogenic reagents alizarin
(I), alizarin red S (II) and quinalizarin (III) producing charge transfer complexes in alcoholic med-
ium which showed an absorption maximum at 528, 505 and 560 nm for I, II and III, respectively.
The optimization of the reaction conditions such as the type of solvent, reagent concentration and
reaction time was investigated. Beer’s law is obeyed in the concentration ranges 1.0–16, 0.5–12 and
2.0–20 lg mL1 for I, II and III, respectively. The molar absorptivity, Sandell sensitivity, detection
and quantiﬁcation limits are also calculated. The correlation coefﬁcient wasP0.9993 (n= 6) with a
relative standard deviation (R.S.D.) of 6 1.13. The methods are successfully applied to the determi-
nation of DES in pharmaceutical formulations and the validity assesses by applying the standard
addition technique, which compared with those obtained using the reported method.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Desloratadine (DES), 4-(8-chloro-5,6-dihydro-11H-benzo-
[5,6]cyclohepta [1,2b]pyridin-11-ylidene)-1-piperidine, (DES is
the descarboethoxy form of loratadine) (Fig. 1). An orally
active major metabolite of the nonsedating antihistamine
loratadine, is a selective, potent, peripheral H1 receptor antag-
onist (Kleemann and Engels, 2000; Graul et al., 2000). Desl-
oratadine exhibits qualitatively similar pharmacodynamic
activity with a relative oral potency in animals, two to three-
fold greater than its parent analog loratadine, probably due
to a higher afﬁnity for histamine H1 human receptors (Hand-
NH
N
Cl
Figure 1 Structural formula of desloratadine (DES).
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increased potency will continue to challenge the analytical
chemist to lower the limit of quantitation (LOQ).
Several analytical methods have been reported for the
determination of DES in biological samples and applied in
pharmacokinetic studies. These methods include gas chroma-
tography with nitrogen phosphorous detection (Johnson
et al., 1994), liquid chromatography with ﬂuorescence detec-
tion (Zhang and Blume, 1994; Yin et al., 2004), ultraviolet
detection (Liu et al., 2004; Qi et al., 2005; EL-Enany et al.,
2007; El-Sherbiny et al., 2007; Zheng and Rustum, 2010), or
mass spectrometric detection (Yang et al., 2003; Srinubabu
et al., 2007; Shen et al., 2006; Zhang et al., 2003). However,
DES was determined in pharmaceutical preparations using
capillary isotachophoresis (Kubacak et al., 2005) and stabil-
ity-indicating UPLC method (Rao et al., 2010).
For determination of DES in tablets using spectrophoto-
metric technique; ultraviolet spectrophotometric methods at
282.5 nm (Patel et al., 2004) and 242 nm (Bondili and Reddy,
2011) were reported. Visible spectrophotometric methods used
eosin (Abd El-Hay et al., 2011), 2,4-dichloro-6-nitrophenol
(DCNP), 2,4-dinitrophenol (DNP) and picric acid (PA)
reagents (Mohamed et al., 2011), 7,7,8,8-tetracyanoquinodi-
methane (TCNQ, p-acceptor) (Cag˘lar and Oztunc¸, 2007), 4-
chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) and 2,4-dini-
troﬂuorobenzene (DNFB) (EL-Enany et al., 2007). Also Spec-
troﬂuorimetric methods were reported for determination of
DES (EL-Enany et al., 2007; Walash et al., 2011). Comparison
between the reported spectrophotometric methods for determi-
nation of DES and the proposed methods was shown in Table
1. The proposed methods are highly speciﬁc for DES in the
presence of the parent drug (loratadine) which contains a sin-
gle basic center pyridine nitrogen atom. The developed three
methods are very simple and less time consuming than other
methods. Also, it does not require extraction and heating).
The charge transfer complex formation with alizarin deriva-
tives by some pharmaceutical compounds was studied such as;
sulfamethoxazole and trimethoprim (IssaandAmin, 1994); pirox-
icam and tenoxicam (Amin, 2002) and nefopam, mebevrine and
phenylpropanolamine hydrochloride (Shama and Amin, 2004).
In the present work, we report a very simple, rapid, accu-
rate, and sensitive visible spectrophotometric method to assay
DES in raw material in some commercial pharmaceutical prep-
arations (tablets). The proposed colorimetric method involves
the formation of charge transfer complex between DES and
alizarines derivatives; alizarin (I), alizarin red S (II) and quinal-
izarin (III) as chromogenic reagents.2. Experimental
2.1. Apparatus
All the absorption spectral measurements were made using
Varian double beam UV–Vis spectrophotometer (Tokyo,
Japan) equipped with 10 mm matched quartz cells.
2.2. Materials and reagents
All solvents (methanol, dimethyl sulfoxide, ethanol, acetone
and acetonitrile) used in this work were of HPLC grade.
Desloratadine reference standard and bulk powder was
supplied from Delta Pharma, Egypt. Its purity was found to
be 99.78% according to the manufacturer’s method. The com-
mercial formulations used included Aerius tablets labeled to
contain (5.0 mg/tablet, Schering-Plough Cooperation, USA)
and Desa tablets labeled to contain (5.0 mg/tablet, Delta Phar-
ma, Egypt).
2.2.1. Standard solutions
A standard stock solution of the studied drugs containing
100 lg mL1 was prepared by dissolving 10 mg of pure drug
in 20 mL methanol and was further diluted to 100 mL with
the same solvent to obtain the working concentration. The
standard solution was kept in refrigerator and was found to
be stable for at least 1 week if they had been stored in a cool
(<25 C) and dark place.
2.2.2. Reagents
Alizarin, 1,2-dihydroxyanthraquinone (I), alizarin red S, 3,4-
dihydroxy-9, 10-dioxo-2-anthracene sulfonic acid (II) and
quinalizarin 1,2,5,8-tetrahydroxy-anthraquinone (IV) were Al-
drich products and used without further puriﬁcation. A stock
solution 3.0 · 103 M was prepared by dissolving the appro-
priate weight of the reagent in approximately 25 mL of meth-
anol. After obtaining a solid-free solution, it was transferred to
a 100 mL volumetric ﬂask and the volume was completed to
the mark with methanol. This solution was stable for 1 week,
at least.2.3. Construction of calibration curves
Aliquots of methanolic solutions containing (0.05–2.0 mL) of a
standard solution of DES (100 lg mL1) were transferred to
separated 10 mL calibrated ﬂasks. To each ﬂask was added
2.0 mL of (3.0 · 103 M) chromogenic reagent (I–III) solution.
Afterward, the obtained mixture was shaken in order to pro-
mote the reaction and the volume was completed to the mark
with methanol. The absorbance of this ﬁnal solution was mea-
sured at 528, 505 and 560 nm for I, II and III, respectively
against a reagent blank. Perform a linear regression analysis
using absorbance data vs. concentration of the drug. Use the
slope and intercept data obtained from linear regression anal-
ysis of the calibration graph to calculate the concentration of
an unknown sample.
Absorbance ¼ interceptþ ðslope X concentrationÞ
Alternatively, the concentration of the unknown may be di-
rectly obtained by calibration graphing.
Table 1 Comparison between the reported spectrophotometric methods for determination of DES.
Reagent kmax nm Concentration
range (lg mL1)
Molar absorptivity
(L mol1 cm1)
LOD (lg mL1) Refs.
UV-spectrophotometry 282.5 16–24 – – Patel et al. (2004)
242 2.0–10 – 0.11 Bondili and Reddy (2011)
Eosin 549 0.31–2.81 – – Abd El-Hay et al. (2011)
2,4-Dichloro-6-nitrophenol (DCNP) 402 3.11–93.35 6.14x105 2.132 Mohamed et al. (2011)
2,4-Dinitrophenol (DNP) 426 3.11–62.17 13.72 · 105 1.884
Picric acid (PA) 352 3.11–43.44 17.08 · 105 0.559
7,7,8,8-Tetracyanoquinodimethane
(TCNQ)
843 1.5–13 2.2968 · 104 0.35 Cag˘lar and Oztunc¸ (2007)
4-Chloro-7-nitrobenzo-2-oxa-1,
3-diazole (NBD-Cl)
485 0.5–6 – 0.112 EL-Enany et al. (2007)
2,4-Dinitroﬂuorobenzene (DNFB) 375 1.0–10 – 0.172
Alizarin (I) 528 1.0–16 1.6078 · 104 0.21 Proposed methods
Alizarin red S (II) 505 0.5–12 2.1836 · 104 0.08
Quinalizarin (III) 560 2.0–20 1.5213 · 104 0.40
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The contents of ten tablets were removed and ﬁnely powdered
using an agate mortar. The combined contents were mixed and
weighed accurately. A portion of the powder equivalent to
50 mg of DES was accurately weighed and exactly 25 mL of
methanol was added, sonicated for about 20 min, left for a
time in a refrigerator to allow any insoluble matter to settle
down and then ﬁltered into a 50 mL volumetric ﬂask. The
solution was then completed to volume with methanol and
the procedure was completed as described for preparing the
calibration graph. The nominal contents of the tablets were
determined either from the calibration graph or using the cor-
responding regression equation.
2.5. Stoichiometric relationship
The stoichiometric ratios of the charge transfer complexes
formed between DES and I–III reagents were determined by
applying the continuous variation method attributable to Job
(Job, 1939) and modiﬁed by Vosburgh and Coober (1941) at
the optimum wavelengths of maximum absorbance. Job’s
method of continuous variation was employed, a
3.0 · 103 M standard solution of DES and 3.0 · 103 M solu-
tion of reagent (I–III) were used. A series of solution were pre-
pared in which the total volume of drug and reagent was kept
at 2.0 mL. The reagents were mixed in various proportions
with drug and diluted to volume in a 10 mL calibrated ﬂask
with methanol following the above mentioned procedures.
3. Results and discussion
Alizarin derivative reagents were utilized for the determination
of DES. The procedure depends on the formation of charge
transfer complex upon the reaction of these reagents with
DES alcoholic medium. The reaction proceeds through the
formation of a charge transferred colored product, which
was measured spectrophotometrically.
The study and development of the methods for the determi-
nation of DES in bulk powders and pharmaceutical formula-
tions, exploring its charge transfer reaction with alizarin
derivatives (I–III), were performed through two steps: (i) opti-
mization of the experimental conditions in order to achieveboth maximum sensitivity and selectivity. This step comprised
the evaluation of the effect of the solvent nature, investigation
of the inﬂuence of the reagent concentration and evaluation of
the time required to complete the reaction and; (ii) study and
characterization of the reaction, which were carried out by
the evaluation of the reaction stoichiometry (Job’s continuous
variation method) and the veriﬁcation of the proposed reac-
tion mechanism.
At optimum conditions, the radical anion (absorbing spe-
cies) was formed in the medium immediately after mixing of
the reagents and showed maximum absorption at 528, 505
and 560 nm for I, II and III, respectively in methanol medium.
Thus, these wavelengths were chosen for all further measure-
ments in order to obtain highest sensitivity for the proposed
methods. It is important to point out that I, II and III alone,
in methanol medium, exhibit maximum absorption at 428,
421 and 491 nm, respectively. The high difference between
maxima of the reagent and the product absorption bands
100, 84 and 69 nm for I, II and III, respectively allowed
the measurement of the products with only a small contribu-
tion of the reagents that were added in excess in the medium
(Fig. 2).
3.1. Evaluation of the effect of the solvent nature
The ﬁrst parameter evaluated in the optimization of the exper-
imental conditions was the nature of the solvent employed.
The solvent plays an important role in some charge transfer
reactions, since it must be able to facilitate the total charge
transfer and then allow the complex dissociation and stabiliza-
tion of the radical anion formed, which is the absorbing spe-
cies. According to the literature, solvents with high dielectric
constant are more effective to execute this task (Kelani et al.,
1997; Huang et al., 2006). Taking this fact into account, water
would be an excellent solvent for the procedure. However, the
poor solubility of the reagents in water did not allow its use in
the present case. So, the reaction was tested in ethanol, meth-
anol, acetone, DMSO and acetonitrile media. Although the
highest dielectric constant of DMSO and acetonitrile and best
sensitivity were achieved with methanol, probably because of
the capacity of this solvent to form stable hydrogen bonds with
the radical anion. Then, methanol was chosen for further
experiments (Fig. 3).
Figure 2 Spectra of charge transfer complexes of 10 lg mL1
DES with (3.0 · 103 M) alizarine derivatives (I–III) in methanol
solvent obtained against the reagent solutions also prepared in the
same solvent.
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Figure 3 Effect of different solvents on the charge transfer
complex of DES-III complex obtained against III reagent solution
also prepared in each solvent. DES concentration = 10 lg L1
and reagent III concentration = (3.0 · 103 M).
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Figure 4 Effect of (3.0 · 103 M) reagent concentration on the
absorbance of charge transfer complexes formed between DES
(10 lg mL1) and the reagents at the optimum wavelengths.
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In spectrophotometric analytical methods where maximum
sensitivity is desired, the reagent concentration in solution is
an important parameter to be studied, since the maximum con-
version of the analyte into absorbing species depends on the
amount of the reagent available in the solution for reaction
and the equilibrium involved. In order to achieve this objective,
an experiment was performed when various concentrations of
reagents (I–III) solution (3.0 · 103 M) in the range of 0.25–
4.0 mL were added to a ﬁxed drug concentration (10 lg mL1)
(Fig. 4). The results showed that 2.0 mL of (3.0 · 103 M) re-
agents solution (I–III) was enough to develop the color to its
full intensity. As it can be seen, remarkable increase of the
absorbance was veriﬁed up to respectively, after this point, it
only suffered a slight increase or constant absorbance.
3.3. Effect of the reaction time
The optimum reaction time was determined by continuous
monitoring of the absorbance at optimum wavelengths of a
solution containing 10 lg mL1 DES plus 2.0 mL of
(3.0 · 103 M) (I–III) reagent, respectively at laboratory ambi-
ent temperature (25 ± 2 C). On raising the temperature, the
absorbance of the charge transfer complex was decreased with
a hypochromic shift, until decayed at 60 C. Stable absorbance
values were observed from the beginning of the experiment up
to 12 h. After this time, absorbance suffered a slight decrease.
In view of these results, all spectral measurements were carried
out after 3.0 min of mixing of the reagents and 25 ± 2 C in
order to make the method faster.
3.4. Sequence of additions
Drug–reagent–solvent was the favorable sequence of addition
for complete color development and highest absorbance at
the recommended wavelength.3.5. Stoichiometry of the reaction
Job’s method of the continuous variation (Job, 1939) was em-
ployed to determine the stoichiometry of the charge transfer
reaction in methanol medium. Keeping the sum of the molar
concentrations of the investigated drug (DES) and (I–III) re-
agents ﬁxed, the ratio of the concentrations of the two sub-
stances in the mixture was varied and the absorbances of the
mixtures were recorded at optimum wavelengths against a con-
venient blank solution prepared for each point of the experi-
ment. As shown in Fig. 5, the molar ratio which gave
maximum absorbance was 0.33, indicating that they react with
(I–III) in a proportion of (1:2) (Drug:reagent) and conﬁrming
the assumption raised before when the effect of reagent con-
centration was studied. In view of this result a reaction mech-
anism was proposed considering the transfer of free electron of
the two nitrogen atoms present in one molecule of drug to the
charge-deﬁcient center of the reagent molecule.
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Figure 5 Job’s method of continuous variation between DES
and Alizarines reagents (I–III).
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Solutions of reagents in methanol exhibit an absorption band
with a well deﬁned maximum at 428, 421 and 491 nm, respec-
tively, while the drug solution in methanol showed no absorp-
tion in the 400–700 nm range. The addition of drug to the
reagent solution in methanol caused an immediate change in
the absorption spectrum with the appearance of a new charac-
teristic band with maximum absorption at optimum wave-
lengths recorded in Table 2.
According to (Ayad et al., 1984) molecular charge-transfer
complexes are formed in non-polar solvents while radical an-
ion species are predominant in polar solvents. Also, it is be-
lieved that the addition of basic compounds that contain a
lone pair of electrons, such as DES, results in the formation
of charge-transfer complexes of n–p type. This kind of com-
plexes can be considered as an intermediate molecular-associ-Table 2 Spectral characteristics of the colored products of DES wi
Parameters Reagents
I
Wavelength (kmax, nm) 528
Concentration range (lg mL1) 1.0–16
Ringbom conc. range (lg mL1) 2.0–14
Molar absorptivity · 104 (L mol1 cm1) 1.6078
Sandell sensitivity (ng cm2) 19.33
Regression equation a
Slope 0.0521
Intercept 0.0007
Correlation coeﬃcient 0.9998
Mean recovery %± SD 99.53 ± 0.5
Variance 0.270
Relative standard deviationb (%) 0.52
Detection limits (lg mL1) 0.21
Quantiﬁcation limits (lg mL1) 0.67
Calculated t-value (2.20)c 0.456
Calculated F-value (4.39)c 3.92
a A= a+ bC, where C is the concentration in (lg mL11), A is the a
b Average of six determinations.
c The ﬁgures between parentheses are the tabulated t and F values, r
p= 0.05 Miller and Miller (2005).ation compound that forms a corresponding radical anion in
polar solvents. In this case, radical anions result from the total
transfer of charge (Fig. 6).
3.7. Validation of the proposed methods
The validity of the methods was tested regarding linearity,
speciﬁcity, accuracy, repeatability and precision according to
International Conference on Harmonization (ICH, 1996) and
United States Pharmacopeia (USP, 1999) guidelines.
Linearity – By using the above procedures, linear regression
equations were obtained. The regression plots showed that
there was a linear dependence of the analytical response in
the three methods to the concentration of the drug over the
ranges cited in Table 2. Linear regression analysis of the data
gave the following equations. For Method I, A= 0.0007 +
0.0521C, r= 0.9998, for method II, A= 0.0072 + 0.0617C,
r= 0.9993 and for method III, A= 0.0084 + 0.0509C,
r= 0.9998. Where A is the absorbance, C is the concentration
of the drug (lg mL1), and r is the correlation coefﬁcient.
The limit of quantiﬁcation (LOQ) was determined by estab-
lishing the lowest concentration that can be measured accord-
ing to ICH, 1996. The results are shown in Table 2. The limits
of detection (LOD) were determined by establishing the mini-
mum level at which the analyte can be reliably detected, and
the results are also summarized in Table 1. LOQ and LOD
were calculated according to the following equation (USP,
1999):
LOQ ¼ 10 s=b
LOD ¼ 3:3 s=b
where s is the standard deviation of the intercept of the regres-
sion line. b: is the slope of the calibration curve.th the reagents (I–III).
II III
505 560
0.5–12 2.0–20
1.0–11 3.5–18
2.1836 1.5213
14.23 20.43
0.0617 0.0509
0.0072 0.0084
0.9993 0.9998
2 99.91 ± 1.13 100.09 ± 0.69
1.277 0.476
1.13 0.69
0.08 0.40
0.26 1.34
0.353 1.14
1.20 2.23
bsorbance, a is the intercept and b is the slope.
espectively for ﬁve degree of freedom and 95% conﬁdence level at
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percent relative error (% Er) and the precision as percent rel-
ative standard deviation (% RSD) (Tables 3).3.7.1. Precision
The precision of the proposed methods was investigated by
intraday and interday determinations of DES at four different
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S1718 A.A. Gouda, M. Kasssemconcentrations of DES solution for each method. The intraday
studies were performed in one day (for each level n= 5) and
interday studies in ﬁve days. The inter-day and intraday preci-
sions expressed as relative standard deviation (RSD) values
were found to be within 0.39–1.42% and 0.35–1.17%, respec-
tively (Table 3). The data proved good precision for the devel-
oped methods.
3.7.2. Accuracy
To check the accuracy of the proposed methods, the standard
addition method was applied by adding known amounts of
DES to a previously analyzed tablet solution. The recovery
of the added drug was calculated by comparing the concentra-
tion of the spiked mixtures with that of the previously found
value. As can be seen from Table 4, satisfactory results better
than the reported spectrophotometric methods were obtained.
3.7.3. Ruggedness and robustness
The robustness of the proposed methods was examined by
evaluating the inﬂuence of small variations in the procedure
variables, such as time of the reaction (3.0 ± 0.5 min), added
reagent volume (2.0 ± 0.1 mL), and using a different instru-
ment, by two different analysts under the same optimized con-
ditions. The obtained reproducible results (Table 5) showed
that none of these variables and changes signiﬁcantly affected
the assay of DES.
3.8. Analysis of the pharmaceutical preparation
The proposed methods were applied to the determination of
DES in commercial tablets (Aerius and Desa tablets). The
methods were tested for linearity, speciﬁcity, accuracy, repeat-
ability, and precision according to ICH recommendations. The
results of the proposed methods were statistically compared
with those obtained using the reference method (EL-Enany
et al., 2007). Recovery ± SD values were obtained. Statistical
analysis of the results, using Student’s t-test and the variance
ratio F-test revealed no signiﬁcant difference between the per-
formance of the proposed and reference methods regarding the
accuracy and precision, respectively (Table 6) (Miller and Mill-
er, 2005).
3.8.1. Speciﬁcity and effect of excipients
The speciﬁcity of the methods was investigated by observing
any interference encountered from the common tablet excipi-
ents, such as starch, lactose, glucose, talc, microcrystalline cel-
lulose, titanium dioxide, lactose monohydrate, fructose,
sucrose, and magnesium stearate. These excipients did not
interfere with the proposed methods.
4. Conclusion
The developed three methods are very simple and rapid. It
does not require extraction, heating, a buffer, or any other
solutions. The chromophore formed is quite stable. Being sim-
ple, rapid, sensitive, accurate, robust, and economic, these
characteristics make the proposed methods very suitable for
routine analysis of DES in quality control laboratories. Mean-
while, the proposed methods are highly speciﬁc for the deter-
mination of DES in the presence of the parent drug
(loratadine).
Table 4 Application of the standard addition technique for the determination of DES in pharmaceutical preparations using the
proposed methods.
Sample Taken (lg mL1) Added (lg mL1) Aerius tablets Desa tablets
Recoverya (%) Recoverya (%)
I 2.0 – 99.30 100.0
4.0 100.15 99.10
6.0 100.70 99.60
8.0 99.80 99.70
10 100.30 100.50
12 99.40 100.80
Mean ± SD 99.94 ± 0.542 99.95 ± 0.622
V 0.294 0.387
RSD 0.542 0.622
S.E 0.222 0.254
II 1.0 – 100.20 99.80
2.0 100.10 99.00
4.0 99.55 99.60
6.0 98.90 100.20
8.0 99.20 100.50
10 99.80 99.30
Mean ± SD 99.63 ± 0.510 99.73 ± 0.557
V 0.260 0.311
RSD 0.512 0.559
S.E 0.208 0.228
III 2.0 – 99.60 100.50
2.0 99.45 100.10
4.0 99.95 99.10
8.0 99.20 99.70
12 100.40 100.30
16 100.20 99.60
Mean ± SD 99.80 ± 0.462 99.88 ± 0.515
V 0.213 0.266
RSD 0.463 0.516
S.E 0.188 0.210
a The average of at least three determinations.
Table 6 Application of the proposed methods to the determination of DES in pharmaceutical preparations.
Samples References method EL-Enany et al. (2007) Proposed methodsa
I II III
Aerius tablets
X ± SD 99.56 ± 0.95 99.85 ± 0.86 99.65 ± 1.02 99.70 ± 0.78
t-Value (2.26)b 0.482 0.136 0.243
F-value (5.19)b 1.22 1.15 1.48
Desa tablets
X ± SD 99.90 ± 0.88 100.10 ± 0.74 99.48 ± 0.93 100.06 ± 0.69
t-Value (2.26)b 0.37 0.691 0.305
F-value (5.19)b 1.41 1.12 1.63
a Average of six determinations.
b The ﬁgures between parentheses are the tabulated t and F values, respectively for ﬁve degree of freedom and 95% conﬁdence level at
p= 0.05 Miller and Miller (2005).
Table 5 Results from robustness experiments.
Changed parameter The proposed methods
I II III
Recovery (%) RSD (%) Recovery (%) RSD (%) Recovery (%) RSD (%)
Added reagent volume 2.0 + 0.1 99.96 0.854 99.94 0.746 99.85 0.668
2.0–0.1 99.90 0.92 100.30 0.882 100.60 0.845
Time of reaction 3.0 + 0.5 100.05 0.680 100.20 0.560 100.10 0.690
3.0–0.5 100.0 0.759 99.90 0.904 100.40 0.775
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